mRNA |
Rapamycin |
GDSC1000 |
pan-cancer |
AAC |
0.076 |
0.1 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.056 |
0.1 |
mRNA |
tretinoin:carboplatin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.053 |
0.1 |
mRNA |
JQ-1:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.051 |
0.1 |
mRNA |
dacarbazine |
CTRPv2 |
pan-cancer |
AAC |
-0.048 |
0.1 |
mRNA |
OSI-906 |
CTRPv2 |
pan-cancer |
AAC |
0.053 |
0.1 |
mRNA |
AR-42 |
GDSC1000 |
pan-cancer |
AAC |
-0.045 |
0.1 |
mRNA |
AT-7519 |
GDSC1000 |
pan-cancer |
AAC |
0.044 |
0.1 |
mRNA |
isonicotinohydroxamic acid |
CTRPv2 |
pan-cancer |
AAC |
-0.069 |
0.1 |
mRNA |
BRD-K80183349 |
CTRPv2 |
pan-cancer |
AAC |
0.048 |
0.1 |